Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
136.02
+2.02 (1.51%)
At close: Dec 20, 2024, 4:00 PM
136.50
+0.48 (0.35%)
After-hours: Dec 20, 2024, 7:57 PM EST
Illumina Revenue
Illumina had revenue of $1.08B in the quarter ending September 29, 2024, a decrease of -3.49%. This brings the company's revenue in the last twelve months to $4.39B, down -1.68% year-over-year. In the year 2023, Illumina had annual revenue of $4.50B, down -1.75%.
Revenue (ttm)
$4.39B
Revenue Growth
-1.68%
P/S Ratio
4.92
Revenue / Employee
$328,593
Employees
13,360
Market Cap
21.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4.50B | -80.00M | -1.75% |
| Jan 1, 2023 | 4.58B | 58.00M | 1.28% |
| Jan 2, 2022 | 4.53B | 1.29B | 39.73% |
| Jan 3, 2021 | 3.24B | -304.00M | -8.58% |
| Dec 29, 2019 | 3.54B | 210.00M | 6.30% |
| Dec 30, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Jan 1, 2017 | Pro | Pro | Pro |
| Jan 3, 2016 | Pro | Pro | Pro |
| Dec 28, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Koninklijke Philips | 20.12B |
| Teva Pharmaceutical | 16.77B |
| Labcorp Holdings | 12.71B |
| Biogen | 9.61B |
| Zimmer Biomet Holdings | 7.60B |
| STERIS | 5.33B |
| BeiGene | 3.35B |
| Waters | 2.91B |
ILMN News
- 4 days ago - Ovation.io and Illumina Collaborate to Advance Genomic Data Research - Business Wire
- 16 days ago - 11 Ultra SWAN Bargains That Could Thrive As The Market Soars To Record Highs - Seeking Alpha
- 17 days ago - Illumina To Webcast Upcoming Investor Conference - PRNewsWire
- 17 days ago - Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications - PRNewsWire
- 18 days ago - Illumina, Inc. (ILMN) CFO Ankur Dhingra Hosts Annual Evercore ISI HealthCONx Healthcare Conference (Transcript) - Seeking Alpha
- 4 weeks ago - Illumina, Inc. (ILMN) CFO Ankur Dhingra Hosts Wolfe Research 2024 Healthcare Conference (Transcript) - Seeking Alpha
- 4 weeks ago - Illumina announces expansion of TruSight Oncology portfolio - PRNewsWire
- 6 weeks ago - Illumina To Webcast Upcoming Investor Conferences - PRNewsWire